Drug Development from Discovery Through Approval
- Intermediate
Discern how unmet needs are identified and translated into new drug development.
Explain clinical study design techniques and describe the key phases of drug development.
Explore emerging therapies, evaluating their risks, opportunities, and potential impact on patients and the health care industry.
Articulate the key considerations and processes involved in initiating a new drug discovery program.
Describe the regulatory landscape and approval processes for novel therapeutics in the U.S. compared to global counterparts.
In Drug Development from Discovery Through Approval, led by Jennifer Leeds, BSc, PhD, you will gain an overview of the drug discovery and development process.
Uncover insights into the complexities and decision points that define the U.S. drug development lifecycle. Trace the drug discovery and development process from initial discovery to regulatory approval. Along the way, examine key decision points, stakeholder roles, and emerging technologies that influence the success of drug candidates and the delivery of innovative therapies to patients.
This course provides an introduction to the drug discovery and development process in 3-4 hours in an on-demand format.